In The News

In The News

MD+DI | March 21, 2018
Quanterix teams up with DestiNA to develop assays to detect liver toxicity in patients.
Bloomberg | February 05, 2018
Bloomberg reporter Anne Mostue interviews Kevin Hrusovsky in segment called, "The Race to Diagnose CTE in the Living"
Quartz | February 03, 2018
"What we need is collaboration among scientists, researchers, the NFL and other contact sports governing bodies to develop a blood test that can be used to monitor players’ brain health, as a blood test is a better alternative to CT scans and subjective tests that are entrenched in current protocol…
SelectScience Interview | January 31, 2018
Ultrasensitive Simoa technology to advance research into tumor-derived exosomes at the University of Pittsburgh Cancer Institute, led by Theresa Whiteside, professor of pathology
SelectScience Interview | January 29, 2018
Bonnie Howell, Executive Director at Merck, discusses the use of ultrasensitive Quanterix technology to develop novel therapies for HIV and shares her hopes for a future world, free of the disease
SelectScience Interview | January 29, 2018
Ralph McDade explains the importance of using ultra-sensitive immunoassays from Quanterix

This website uses cookies. By continuing to use this website you are acknowledging and agree with our cookie policy.

AgreeLearn more